UNICEF & Moderna

UNICEF: UNICEF is concerned about the impact of the Ebola outbreak on children, especially given high malnutrition levels and patchy vaccination rates in affected areas, and is dispatching urgent medical supplies.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

UNICEF: UNICEF>>> has mobilized supplies and an Emergency Rapid Response team to provide technical assistance and support for risk communication and community engagement in the affected areas.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.

UNICEF: UNICEF is a partner in the ICG, supporting vaccine distribution and child health initiatives during the outbreak.

Moderna: Authorized to begin Phase 1 trials for a Bundibugyo vaccine, using mRNA technology. Potential for significant revenue if successful.

UNICEF: UNICEF has sent initial relief supplies, including disinfectants, protective equipment, and water purification tablets, to Bunia to aid in the Ebola response.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.